Keywords: prostrakan, revenue, up, scottish, drugmaker, prostakan, says
ProStrakan's 2008 revenue up 23%
Article | 30 March 2009
Scottish drugmaker Prostakan says that product sales in 2008 rose 32% on the year before to GBP53.8 million ($75.8 million), as total revenues ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
